Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Druggable genomic landscapes of high-grade gliomas

Frontiers in Medicine(2023)10.3389/fmed.2023.1254955Source: DataRank Database

Druggable genomic landscapes of high-grade gliomas is a research paper published in Frontiers in Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.46)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Maria Fatteh,David Kamson ORCID,Archana Balan ORCID,Michael Chang ORCID,Jessica J. Tao ORCID

Live enrichment

PubMed:38143440 PMC:PMC10749203 OpenAlex:https://openalex.org/W4389565862

NCI NIH HHS

Grant: U01 CA274631

NCI NIH HHS

Grant: P30 CA006973

NCI NIH HHS

Grant: R01 CA121113

National Institutes of Health

Grant: 1U01CA274631-01A1

Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 5R01CA121113-04

Large-scale Genetic Analyses of Gene Families in Colorectal Cancer

FWCI

2.46

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fmed.2023.1254955/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fmed.2023.1254955/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fmed.2023.1254955/full

journalhttps://doi.org/10.3389/fmed.2023.1254955

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38143440

Fields of Study

Glioma Diagnosis and TreatmentCancer Research and TreatmentsCancer Mechanisms and Therapy0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

TrametinibIDH1PDGFRAMedicineGliomaCDKN2AOncologyDabrafenibInternal medicinePTENMelanomaNeuroblastoma RAS viral oncogene homologTargeted therapyCohortMEK inhibitorCancer researchKRASCancerBiologyGeneMutationVemurafenibGeneticsMAPK/ERK pathwayMetastatic melanomaPI3K/AKT/mTOR pathwayKinaseColorectal cancerGlioblastomaTargeted TherapiesPrecision OncologyMolecular Tumor BoardGenomic LandscapeActionable MutationMedicine (General)R5-920

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being